{"id":"iv-iron-infusion","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (pain, discoloration)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Hypersensitivity reactions"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iron is an essential component of hemoglobin and myoglobin, required for oxygen transport in red blood cells and muscle tissue. IV iron bypasses gastrointestinal absorption limitations, allowing rapid repletion of depleted iron stores in patients with iron deficiency anemia who cannot tolerate or absorb oral iron supplementation. This restores oxygen-carrying capacity and alleviates anemia-related symptoms.","oneSentence":"IV iron infusion delivers iron directly into the bloodstream to replenish iron stores and treat iron deficiency anemia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:50:32.764Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in women and children in resource-limited settings"},{"name":"Iron deficiency anemia in pregnancy"},{"name":"Iron deficiency anemia in postpartum women"}]},"trialDetails":[{"nctId":"NCT05385042","phase":"NA","title":"Iron and Immune Response to Vaccine (IRONMUM)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-06-18","conditions":"Pregnancy Related","enrollment":171},{"nctId":"NCT02511028","phase":"PHASE1","title":"In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2015-11-27","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT06884280","phase":"PHASE3","title":"Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study","status":"RECRUITING","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2025-11-13","conditions":"Peritoneal Dialysis, Anaemia, Iron Deficiency, Anaemia","enrollment":30},{"nctId":"NCT06287619","phase":"PHASE2","title":"Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-04-03","conditions":"Chronic Iron Deficiency Anaemia, Cardiac Surgery","enrollment":60},{"nctId":"NCT07384663","phase":"PHASE1","title":"EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY","status":"COMPLETED","sponsor":"Dr Salaha Azam","startDate":"2025-06-01","conditions":"Iron Deficiency Anaemia in Childbirth","enrollment":112},{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT07197905","phase":"PHASE2","title":"Restoring Iron Deficiency in POTS","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-11-24","conditions":"POTS - Postural Orthostatic Tachycardia Syndrome","enrollment":12},{"nctId":"NCT04900792","phase":"PHASE1","title":"A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bryan Allen","startDate":"2023-02-28","conditions":"Glioblastoma, Glioblastoma Multiforme","enrollment":17},{"nctId":"NCT01374919","phase":"NA","title":"Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2011-06","conditions":"Iron Deficiency Anemia","enrollment":60},{"nctId":"NCT04268849","phase":"PHASE3","title":"Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient","status":"RECRUITING","sponsor":"Auerbach Hematology Oncology Associates P C","startDate":"2020-02-27","conditions":"Iron Deficiency Anemia","enrollment":104},{"nctId":"NCT05067998","phase":"","title":"The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature","status":"RECRUITING","sponsor":"Faith A. Richardson","startDate":"2025-12-21","conditions":"Anxiety Disorders and Symptoms, Fibromyalgia, Arthritis","enrollment":25},{"nctId":"NCT07115121","phase":"NA","title":"Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-02-02","conditions":"Anemia","enrollment":40},{"nctId":"NCT02791568","phase":"","title":"Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-01-31","conditions":"Pregnancy, Obesity, Preeclampsia","enrollment":121},{"nctId":"NCT06833788","phase":"PHASE4","title":"Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Postpartum Depression (PPD)","enrollment":2860},{"nctId":"NCT07053475","phase":"PHASE4","title":"IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches","status":"RECRUITING","sponsor":"Syed Hamza Mufarrih","startDate":"2025-04-02","conditions":"Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":250},{"nctId":"NCT05462704","phase":"PHASE3","title":"Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-01-17","conditions":"Iron Deficiency Anemia, Pregnancy","enrollment":300},{"nctId":"NCT01950247","phase":"PHASE4","title":"Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-08-15","conditions":"Iron Deficiency Anemia (IDA)","enrollment":1025},{"nctId":"NCT06483061","phase":"PHASE2","title":"Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-05-01","conditions":"Epilepsy, Temporal Lobe","enrollment":50},{"nctId":"NCT05816265","phase":"PHASE4","title":"Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure","status":"ENROLLING_BY_INVITATION","sponsor":"Radha Gopalan","startDate":"2024-01-24","conditions":"Heart Failure, Iron-deficiency","enrollment":40},{"nctId":"NCT05407987","phase":"PHASE3","title":"Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2025-04-08","conditions":"Gynecologic Cancer, Anemia, Iron-deficiency","enrollment":82},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":"Iron Deficiency Anemia (IDA), Pregnancy","enrollment":60},{"nctId":"NCT05800600","phase":"PHASE2","title":"Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2023-03-15","conditions":"Anemia","enrollment":34},{"nctId":"NCT06427343","phase":"PHASE4","title":"The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency","status":"RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2023-10-01","conditions":"Heart Failure, Iron Deficiency","enrollment":114},{"nctId":"NCT02631733","phase":"PHASE1","title":"Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-05-31","conditions":"Malignant Solid Neoplasm","enrollment":18},{"nctId":"NCT05353348","phase":"NA","title":"Effect of the Combined Programme on Perioperative Anaemia（CPPA）","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-15","conditions":"Patient Blood Management, Cardiac Surgery, Iron Deficiency Anemia","enrollment":110},{"nctId":"NCT06591182","phase":"","title":"Effects of Social Determinants of Health on IV Iron Treatments","status":"ENROLLING_BY_INVITATION","sponsor":"BayCare Health System","startDate":"2024-11-05","conditions":"Social Determinants of Health (SDOH)","enrollment":130},{"nctId":"NCT05929729","phase":"PHASE4","title":"Iron Deficiency Anemia (IDA) and the Brain","status":"RECRUITING","sponsor":"Children's Hospital Los Angeles","startDate":"2023-12-07","conditions":"IDA - Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia","enrollment":120},{"nctId":"NCT05960227","phase":"PHASE2","title":"Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2023-01-06","conditions":"Anemia, Iron Deficiency, Acute Kidney Injury","enrollment":120},{"nctId":"NCT02907359","phase":"PHASE3","title":"Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs","status":"COMPLETED","sponsor":"Astex Pharmaceuticals, Inc.","startDate":"2017-01-13","conditions":"Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic","enrollment":417},{"nctId":"NCT06556134","phase":"PHASE4","title":"Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Hassan II - Fès","startDate":"2021-07-01","conditions":"Anemia of Chronic Kidney Disease","enrollment":27},{"nctId":"NCT02889133","phase":"NA","title":"Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-01","conditions":"Iron Deficiency","enrollment":79},{"nctId":"NCT03438227","phase":"PHASE4","title":"Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Indiana University","startDate":"2018-04-15","conditions":"Iron Deficiency Anemia of Pregnancy, Iron Malabsorption","enrollment":38},{"nctId":"NCT03074591","phase":"PHASE4","title":"Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-08-01","conditions":"Iron-deficiency, Heart Failure","enrollment":40},{"nctId":"NCT05226169","phase":"PHASE3","title":"Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2022-04-29","conditions":"Advanced Gastric Carcinoma","enrollment":330},{"nctId":"NCT06248749","phase":"PHASE3","title":"Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"University of Saskatchewan","startDate":"2024-02-29","conditions":"Anaemia in Ovarian Carcinoma","enrollment":200},{"nctId":"NCT00135668","phase":"PHASE2","title":"Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room","status":"COMPLETED","sponsor":"The Emmes Company, LLC","startDate":"2005-08","conditions":"Hypotension","enrollment":211},{"nctId":"NCT05590260","phase":"PHASE3","title":"Prevention of Iron Deficiency Anemia Post-delivery","status":"UNKNOWN","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2023-05-30","conditions":"Postpartum Anemia","enrollment":4800},{"nctId":"NCT04205266","phase":"PHASE4","title":"IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2020-02-14","conditions":"Anemia, Iron Deficiency, Heavy Menstrual Bleeding","enrollment":76},{"nctId":"NCT05991128","phase":"PHASE4","title":"The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2023-08-01","conditions":"Heart Failure With Preserved Ejection Fraction, Iron Deficiencies, Acute Heart Failure","enrollment":170},{"nctId":"NCT05047211","phase":"PHASE4","title":"Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2021-10-07","conditions":"Anemia, Iron Deficiency, Delivery Complication","enrollment":40},{"nctId":"NCT05971732","phase":"PHASE4","title":"The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2023-08-01","conditions":"Heart Failure With Reduced Ejection Fraction, Iron Deficiency, Acute Heart Failure","enrollment":146},{"nctId":"NCT01052779","phase":"PHASE2","title":"A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-03-01","conditions":"Iron Deficiency, Anemia, Kidney Disease","enrollment":162},{"nctId":"NCT02694978","phase":"PHASE3","title":"A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2016-02-29","conditions":"Iron Deficiency Anemia","enrollment":2014},{"nctId":"NCT03179449","phase":"EARLY_PHASE1","title":"In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI","status":"WITHDRAWN","sponsor":"Michael Iv","startDate":"2017-07-01","conditions":"Childhood Brain Neoplasm","enrollment":""},{"nctId":"NCT05708170","phase":"PHASE4","title":"Impact of Intravenous Iron on Musculoskeletal Function in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"Liverpool Hope University","startDate":"2023-01","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT03933813","phase":"PHASE1, PHASE2","title":"Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2019-07-29","conditions":"Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia","enrollment":9},{"nctId":"NCT01877837","phase":"PHASE3","title":"Stem Cell Transplantation for Sickle Cell Anemia","status":"COMPLETED","sponsor":"Hackensack Meridian Health","startDate":"2011-06","conditions":"Sickle Cell Disease","enrollment":30},{"nctId":"NCT02642562","phase":"PHASE4","title":"Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN","status":"COMPLETED","sponsor":"University of Glasgow","startDate":"2016-08","conditions":"Chronic Heart Failure, Iron Deficiency, Left Ventricular Systolic Dysfunction","enrollment":1160},{"nctId":"NCT05581420","phase":"NA","title":"Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2022-06-02","conditions":"Inflammatory Bowel Diseases","enrollment":152},{"nctId":"NCT05258825","phase":"PHASE4","title":"Preoperative Monoferric for Abdominal Surgery","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-01","conditions":"Anemia, Surgery","enrollment":32},{"nctId":"NCT00777140","phase":"PHASE2","title":"Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2008-09","conditions":"Ischemic Stroke, Acute","enrollment":62},{"nctId":"NCT03523117","phase":"PHASE3","title":"Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2019-01-31","conditions":"Iron Deficiency Anemia","enrollment":79},{"nctId":"NCT01114204","phase":"PHASE3","title":"A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-08-10","conditions":"Iron Deficiency Anemia","enrollment":605},{"nctId":"NCT05153278","phase":"","title":"IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department","status":"COMPLETED","sponsor":"Texas Tech University Health Sciences Center, El Paso","startDate":"2018-10-26","conditions":"Iron Deficiency Anemia Treatment, Iron-deficiency, Iron Deficiency Anemia Due to Blood Loss","enrollment":130},{"nctId":"NCT05114278","phase":"PHASE4","title":"Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-02-15","conditions":"Celiac Disease","enrollment":204},{"nctId":"NCT04246021","phase":"NA","title":"Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy","status":"COMPLETED","sponsor":"King Hussein Cancer Center","startDate":"2016-06-15","conditions":"Anemia, Cancer","enrollment":84},{"nctId":"NCT05110768","phase":"PHASE2","title":"Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy","status":"UNKNOWN","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2021-11-30","conditions":"Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT03485053","phase":"PHASE2","title":"A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia","status":"TERMINATED","sponsor":"MegaPro Biomedical Co. Ltd.","startDate":"2018-11-29","conditions":"Iron Deficiency Anemia","enrollment":49},{"nctId":"NCT04409132","phase":"PHASE1, PHASE2","title":"Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2020-06-25","conditions":"End Stage Renal Disease","enrollment":23},{"nctId":"NCT03591406","phase":"PHASE3","title":"To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-07-03","conditions":"Iron Deficiency Anemia","enrollment":371},{"nctId":"NCT03574311","phase":"PHASE4","title":"Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2018-10-02","conditions":"Coronary Artery Disease, Postoperative Complications, Aortic Valve Stenosis","enrollment":210},{"nctId":"NCT04042324","phase":"PHASE1, PHASE2","title":"A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2019-09-30","conditions":"End Stage Renal Disease","enrollment":12},{"nctId":"NCT03303144","phase":"PHASE1, PHASE2","title":"Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2017-10-01","conditions":"End Stage Renal Disease","enrollment":27},{"nctId":"NCT02189889","phase":"PHASE1, PHASE2","title":"Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2013-04-09","conditions":"Anemia, Cardiovascular Disease","enrollment":5},{"nctId":"NCT04587141","phase":"PHASE3","title":"Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial","status":"UNKNOWN","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2020-01-01","conditions":"Iron Deficiency Anemia, Inflammatory Bowel Diseases","enrollment":300},{"nctId":"NCT00236977","phase":"PHASE3","title":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-08","conditions":"Anemia","enrollment":182},{"nctId":"NCT02940886","phase":"PHASE3","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2016-11-08","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":1512},{"nctId":"NCT02940860","phase":"PHASE3","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2016-11-29","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia, Chronic Kidney Disease","enrollment":1538},{"nctId":"NCT02862665","phase":"NA","title":"Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical Trial","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-08","conditions":"Complex Valvular Heart Surgery","enrollment":214},{"nctId":"NCT02628860","phase":"PHASE2","title":"Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2014-01","conditions":"Pancreatic Cancer, Anemia","enrollment":40},{"nctId":"NCT04359368","phase":"","title":"Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-09-01","conditions":"Iron-deficiency, Hypersensitivity Reactions","enrollment":42},{"nctId":"NCT02962648","phase":"PHASE3","title":"An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2017-01-09","conditions":"Iron Deficiency Anemia, Iron Deficiency Anaemia","enrollment":103},{"nctId":"NCT03237065","phase":"PHASE3","title":"Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2017-10-30","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":122},{"nctId":"NCT03238911","phase":"PHASE3","title":"Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2017-10-24","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":123},{"nctId":"NCT04168346","phase":"PHASE4","title":"Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2019-11","conditions":"Gastric Cancer, Anemia, Surgery","enrollment":202},{"nctId":"NCT02141490","phase":"PHASE2","title":"Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-05-15","conditions":"Prostate Cancer, Bladder Cancer, Kidney Cancer","enrollment":43},{"nctId":"NCT02636049","phase":"PHASE1","title":"Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2015-10","conditions":"End Stage Renal Disease","enrollment":12},{"nctId":"NCT03286205","phase":"PHASE4","title":"A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.","status":"WITHDRAWN","sponsor":"Sutter Gould Medical Foundation","startDate":"2015-04-14","conditions":"Anemia, Iron Deficiency","enrollment":""},{"nctId":"NCT02767128","phase":"PHASE1","title":"Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2016-04","conditions":"Iron-refractory, Iron-deficiency Anemia (IRIDA)","enrollment":14},{"nctId":"NCT02739100","phase":"PHASE1","title":"Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2016-04","conditions":"End Stage Renal Disease","enrollment":13},{"nctId":"NCT03229954","phase":"PHASE4","title":"Intravenous Iron Isomaltoside 1000 (Monofer®) Compared With Oral Iron in the Treatment of Postgastrectomy Anemia: An Open-label Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2017-08-28","conditions":"Post Gastrectomy Anemia","enrollment":358},{"nctId":"NCT03295851","phase":"PHASE4","title":"Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2017-11-22","conditions":"Anemia, Major Abdominal Surgery, Pre-operative","enrollment":60},{"nctId":"NCT02595437","phase":"PHASE1, PHASE2","title":"Triferic Pediatric Pharmacokinetic Protocol","status":"COMPLETED","sponsor":"Rockwell Medical Technologies, Inc.","startDate":"2015-11-01","conditions":"End Stage Renal Disease","enrollment":22},{"nctId":"NCT03707249","phase":"NA","title":"Iron Status and Cardiopulmonary Physiology","status":"COMPLETED","sponsor":"Royal Centre for Defence Medicine","startDate":"2016-01-19","conditions":"Iron-deficiency, Ventricular Function, Pulmonary Vascular Resistance Abnormality","enrollment":18},{"nctId":"NCT01895231","phase":"PHASE3","title":"A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2013-06","conditions":"Iron-deficiency","enrollment":107},{"nctId":"NCT02123069","phase":"","title":"Vascular Function and Uterine Fibroids","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-04","conditions":"Leiomyoma","enrollment":28},{"nctId":"NCT00580905","phase":"PHASE1","title":"Role of Adenosine in the Release of VEGF and Cytokines","status":"TERMINATED","sponsor":"Vanderbilt University","startDate":"2007-06","conditions":"Inflammation","enrollment":8},{"nctId":"NCT01984554","phase":"","title":"Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-09","conditions":"Iron Deficiency Anemia (IDA)","enrollment":551},{"nctId":"NCT02678767","phase":"PHASE2","title":"Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS","status":"COMPLETED","sponsor":"Beau Nakamoto","startDate":"2015-02","conditions":"AIDS Dementia Complex","enrollment":30},{"nctId":"NCT02541708","phase":"PHASE3","title":"IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania","status":"UNKNOWN","sponsor":"Ifakara Health Institute","startDate":"2015-09","conditions":"Iron-Deficiency Anemia","enrollment":230},{"nctId":"NCT01725789","phase":"PHASE3","title":"Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2012-11","conditions":"Anemia","enrollment":454},{"nctId":"NCT02731378","phase":"PHASE4","title":"Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2016-12","conditions":"Chemotherapy-induced Anaemia","enrollment":603},{"nctId":"NCT02689401","phase":"PHASE1","title":"MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer","status":"WITHDRAWN","sponsor":"Dana-Farber Cancer Institute","startDate":"2016-05","conditions":"Esophageal Cancer","enrollment":""},{"nctId":"NCT00318812","phase":"PHASE2, PHASE3","title":"Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-05","conditions":"Anemia, Renal Failure","enrollment":55},{"nctId":"NCT01309659","phase":"PHASE2","title":"Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia","status":"TERMINATED","sponsor":"Duke University","startDate":"2011-05","conditions":"Anemia, Unexplained Anemia (UAE)","enrollment":19},{"nctId":"NCT02484768","phase":"PHASE2","title":"IV Iron Treatment of Restless Legs Syndrome","status":"WITHDRAWN","sponsor":"Pharmacosmos A/S","startDate":"2015-01","conditions":"Restless Legs Syndrome","enrollment":""},{"nctId":"NCT01599702","phase":"PHASE3","title":"Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2012-05","conditions":"Inflammatory Bowel Disease","enrollment":21},{"nctId":"NCT02213653","phase":"PHASE4","title":"Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency","status":"TERMINATED","sponsor":"Centre Francois Baclesse","startDate":"2013-04","conditions":"Solid Cancer Metastatic Disease, Lymphoid Disease","enrollment":24},{"nctId":"NCT02392910","phase":"PHASE4","title":"Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.","status":"COMPLETED","sponsor":"Hospital Aleman","startDate":"2006-03","conditions":"Iron Deficiency, Heart Failure, Chronic Kidney Disease","enrollment":40},{"nctId":"NCT00746551","phase":"PHASE4","title":"Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2008-09","conditions":"Anemia, Pregnancy Complications","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"HEPATIC ENCEPHALOPATHY"},{"count":1,"reaction":"HOSPITALISATION"},{"count":1,"reaction":"THERAPY CESSATION"}],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ferric carboxymaltose injection"],"phase":"marketed","status":"active","brandName":"IV iron infusion","genericName":"IV iron infusion","companyName":"NICHD Global Network for Women's and Children's Health","companyId":"nichd-global-network-for-women-s-and-children-s-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IV iron infusion delivers iron directly into the bloodstream to replenish iron stores and treat iron deficiency anemia. Used for Iron deficiency anemia in women and children in resource-limited settings, Iron deficiency anemia in pregnancy, Iron deficiency anemia in postpartum women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}